{"SPADE_UN_15541": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15541", "Peptide Name": "Pc", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GCRLYGFKIHGCG", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:Hep-G2 (IC50=30.4 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Protein kinase CK2", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C62H95N19O15S2", "Mass": 1410.67, "PI": 8.9, "Net Charge": 3, "Hydrophobicity": 0.12, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity", "Pubmed ID": "30307134", "Reference": "Mol Inform. 2019 Mar;38(3)e1800089.", "Author": "Tang S, Zhang N, Zhou Y, Cortopassi WA, Jacobson MP, Zhao LJ, Zhong RG.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30307134"}], "Frequent Amino Acids": "GCF", "Absent Amino Acids": "ADEMNOPQSTUVW", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 4, "Polar Residues": 6, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_13788", "Similarity": 1.0, "Sequence": "MRSLLILVLCFLPLAALGKVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINSRWWCNDGRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDVQAWIRGCRL"}, {"SPADE_ID": "SPADE_UN_15539", "Similarity": 0.9230769230769231, "Sequence": "GCRLYGFKFHGCG"}, {"SPADE_ID": "SPADE_UN_15540", "Similarity": 0.9230769230769231, "Sequence": "GCRLYGFKIFGCG"}]}}}